AKTS Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Aktis Oncology Inc (AKTS.O) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting AKTS.O is Strong buy.

Aktis Oncology Inc (AKTS.O) 20-Day simple moving average is 0.08, while Aktis Oncology Inc (AKTS.O) share price is $19.71, making it Buy.

Aktis Oncology Inc (AKTS.O) 60-Day simple moving average is 0.07, while Aktis Oncology Inc (AKTS.O) share price is $19.71, making it Buy.

Technical Analysis for AKTS

Technical Sentiment Analysis for Aktis Oncology Inc (AKTS) As of 2024-12-20, Aktis Oncology Inc (AKTS) is exhibiting a Strong buy technical sentiment. Our proprietary analysis, which aggregates 19 technical signals, shows that 13 indicators are flashing buy, while 6 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for AKTS stands at 28.76, which suggests a Buy condition. Meanwhile, the MACD (12, 26) indicator is at -0.01, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 5.36 and the Commodity Channel Index (CCI) at -132.23 further confirm a -0.06 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, AKTS is trading below its 60-day moving average of $0.07 and below its 200-day long-term moving average of $0.21. Key price levels to watch include the immediate resistance at $0.09 and strong support at $0.03. A break above $0.09 could signal a bull continuation, while falling below $0.03 may test the next Fibonacci floor at $-.

Aktis Oncology Inc (AKTS) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	-0.04	-	0.03	0.06	0.09	0.13	0.16
Fibonacci	-	0.02	0.04	0.06	0.09	0.1	0.13

Aktis Oncology Inc (AKTS) Technical Indicators

2024-12-20

Name	Value
RSI_14	28.76
STOCHk_14_3_3	5.36
STOCHd_14_3_3	4.7
CCI_20	-132.23
AO_5_34	-0.03
MOM_10	-0.06
MACD_12_26_9	-0.01

Aktis Oncology Inc (AKTS) Relative Strength Index (RSI) is 28.76, creating a Buy signal.

Aktis Oncology Inc (AKTS) Stochastic Oscillator is 5.36, creating a Buy signal.

Aktis Oncology Inc (AKTS) Stochastic RSI is 4.7, creating a Buy signal.

Aktis Oncology Inc (AKTS) Commodity Channel Index (CCI) is -132.23, creating a Buy signal.

Aktis Oncology Inc (AKTS) Awesome Oscillator is -0.03, creating a Sell signal.

Aktis Oncology Inc (AKTS) Momentum is -0.06, creating a Sell signal.

Aktis Oncology Inc (AKTS) MACD is -0.01, creating a Sell signal.

Aktis Oncology Inc (AKTS) Moving Average

2024-12-20

Period	Simple	Signal
MA_5	0.04	Buy
MA_10	0.06	Buy
MA_20	0.08	Buy
MA_60	0.07	Buy
MA_200	0.21	Buy
MA_250	0.31	Buy

Aktis Oncology Inc (AKTS) 5-Day simple moving average is 0.04, while Aktis Oncology Inc (AKTS) share price is $19.71, making it a Buy.

Aktis Oncology Inc (AKTS) 10-Day simple moving average is 0.06, while Aktis Oncology Inc (AKTS) share price is $19.71, making it a Buy.

Aktis Oncology Inc (AKTS) 20-Day simple moving average is 0.08, while Aktis Oncology Inc (AKTS) share price is $19.71, making it a Buy.

Aktis Oncology Inc (AKTS) 60-Day simple moving average is 0.07, while Aktis Oncology Inc (AKTS) share price is $19.71, making it a Buy.

Aktis Oncology Inc (AKTS) 200-Day simple moving average is 0.21, while Aktis Oncology Inc (AKTS) share price is $19.71, making it a Buy.

Aktis Oncology Inc (AKTS) 250-Day simple moving average is 0.31, while Aktis Oncology Inc (AKTS) share price is $19.71, making it a Buy.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for AKTS?

The overall technical consensus for Aktis Oncology Inc (AKTS) is currently strong buy. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 7 buy signals and 6 sell signals.

What are the key support and resistance levels for Aktis Oncology Inc (AKTS) today?

Based on pivot point calculations, Aktis Oncology Inc (AKTS) has an immediate support level at 0.03 and a major resistance level at 0.09. Traders also monitor the pivot point at 0.06 to determine the intraday trend direction.

Is Aktis Oncology Inc (AKTS) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Aktis Oncology Inc (AKTS) is currently 28.76. This indicates that the stock is in oversold territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Aktis Oncology Inc (AKTS)?

Aktis Oncology Inc (AKTS) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting AKTS is strong buy. This indicator helps identify potential trend reversals or momentum shifts for Aktis Oncology Inc.

How is Aktis Oncology Inc (AKTS) performing relative to its 200-day moving average?

Aktis Oncology Inc (AKTS)is currently trading at $19.71, which is above its 200-day simple moving average of 0.21. Trading above the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.